MedTrace Logo

Interest of Functional Neuroimaging in Assessing Decision-making Capacity of Older People With Neurocognitive Disorders

NCT03931148 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2021-08-23

No results posted yet for this study

Summary

IMAGISION aims to explore, in a cohort of patients referred for geriatric consultation for neurocognitive evaluation, the contribution of functional neuroimaging (functional MRI and, if possible, high resolution EEG) to geriatric expertise, associated with the performance of a battery of neuropsychological tests in the evaluation of decision-making capacity.

Conditions

Interventions

DIAGNOSTIC_TEST

Geriatric Assesment with neuropsychological test more specific on decision making

The following tests will be made : MoCA, FAB, TMT, Stroop-Victoria, JAT

DIAGNOSTIC_TEST

Functional RMI

With specific test of decision making (IGT) specially adapted to the population

DIAGNOSTIC_TEST

High Resolution EEG

With specific test of decision making (BART) specially adapted to the population

OTHER

Qualitative interview

Qualitative semi-directed interviews with participants, their caregivers and their geriatrician to analyse everyday life decision making ability.

Sponsors & Collaborators

  • Université de Montréal

    collaborator OTHER

  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Regis AUBRY, PhD · Centre Hospitalier Universitaire de Besancon

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-05
Primary Completion
2022-09-30
Completion
2023-04-30

Countries

  • Canada
  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03931148 on ClinicalTrials.gov